---
schema_version: "secwatch.filing_event.v1"
accession: "0001720420-25-000008"
form_type: "8-K"
ticker: "IBEX"
cik: "0001720420"
company_name: "IBEX Ltd"
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:43:36.529140+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IBEX Q2 revenue $140.7M (+6.1% YoY); raises FY guidance; adjusted EPS $0.59

## Summary
- Q2 revenue $140.7M (+6.1% YoY); net income $9.3M (+52.6%); diluted EPS $0.57 vs $0.33 a year ago.
- Adjusted EPS $0.59 (+36% YoY); adjusted EBITDA $16.5M (+15.4%); margin 11.8% vs 10.8%.
- Raised FY2025 revenue guidance to $525-535M (from $515-525M); adjusted EBITDA guidance $68-69M.
- Repurchased 3.6M shares from TRGI for $70M, eliminating controlled company status.
- HealthTech (+31.2%) and Travel/T&L (+16.7%) drove growth; FinTech declined 14.7%.

## SEC filing metadata
- accession: 0001720420-25-000008
- form_type: 8-K
- ticker: IBEX
- cik: 0001720420
- company_name: IBEX Ltd
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/0001720420-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/ibex-20250206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001720420-25-000008
- JSON: https://secwatch.observer/filing/0001720420-25-000008.json
- Plain text: https://secwatch.observer/filing/0001720420-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.